CHICAGO, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)FOUNDATION FOR WOMEN'S CANCER, founded in 1998, is a community nonprofit in the Health Care sector that reported $2.5M in total revenue in fiscal year 2023. The organization ran a surplus of $457K, a strong 18% operating margin.
TO IMPROVE THE CARE OF PATIENTS WITH GYNECOLOGIC CANCER; TO ADVANCE KNOWLEDGE AND RAISE STANDARDS OF PRACTICE IN GYNECOLOGIC ONCOLOGY WITHIN THE DISCIPLINE OF OBSTETRICS AND GYNECOLOGY; TO ENCOURAGE RESEARCH AND COOPERATION WITH OTHER INDIVIDUALS AND ORGANIZATIONS INTERESTED IN ONCOLOGY AND RELATED FIELDS.
THE FOUNDATION ISSUES RESEARCH GRANTS TO PROVIDE A LIAISON/FELLOW TO THE NATIONAL CANCER INSTITUTE AND OTHER CANCER-BASED HEALTH AND MEDICAL AGENCIES. THESE FUNDS ARE ALLOCATED TO PROMOTE AND...
THE FOUNDATION ISSUES RESEARCH GRANTS TO PROVIDE A LIAISON/FELLOW TO THE NATIONAL CANCER INSTITUTE AND OTHER CANCER-BASED HEALTH AND MEDICAL AGENCIES. THESE FUNDS ARE ALLOCATED TO PROMOTE AND INITIATE RESEARCH IN THE FIELD, PROVIDE GRANTS TO THE MEDICAL COMMUNITY FOR FURTHER RESEARCH, AND REPORT FINDINGS RELATED TO GYNECOLOGIC ONCOLOGY.
THE FOUNDATION'S MOVE4HER PROGRAM CONSISTS OF A MONTH OF MOVEMENT TO RAISE FUNDS, INCREASE AWARENESS AND DRIVE EARLY DIANOSIS OF THE 5 GYN CANCERS.
THE FOUNDATION'S SURVIVOR COURSES PROVIDE SUPPORT TO WOMEN AS THEIR GYNECOLOGIC CANCER JOURNEY CONTINUES. THESE COURSES PROVIDE THE MOST CURRENT INFORMATION ABOUT TREATMENT OPTIONS, RESEARCH AND...
THE FOUNDATION'S SURVIVOR COURSES PROVIDE SUPPORT TO WOMEN AS THEIR GYNECOLOGIC CANCER JOURNEY CONTINUES. THESE COURSES PROVIDE THE MOST CURRENT INFORMATION ABOUT TREATMENT OPTIONS, RESEARCH AND QUALITY OF LIFE STRATEGIES TAUGHT BY LEADING EXPERTS, MOST GYNECOLOGIC ONCOLOGISTS. MOST COURSES FOCUS ON SPECIFIC GYNECOLOGIC CANCER - CERVICAL CANCER, OVARIAN CANCER, OR UTERINE CANCER.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,506,604 | $2,355,407 | +0.1% |
| Expenses | $2,049,930 | $1,813,408 | +0.1% |
| Net Income | $456,674 | $541,999 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PIERRE DESY | CEO | 15.00 |
Officer
|
$0 | $32,035 | $296,432 |
| HOLLY GIBOUT | CHIEF DEVELOPMENT OFFICER FWC | 40.00 |
Highest
|
$0 | $11,231 | $216,757 |
| TERI JORDAN | CHIEF INDUSTRY RELATIONS & BDO | 15.00 |
Highest
|
$0 | $15,448 | $209,377 |
| KAYLA WESTMAN | CHIEF OF MEETINGS AND PROF | 40.00 |
Highest
|
$0 | $10,902 | $181,960 |
| ELIZABETH KIX | CHIEF MARKETING & COMM OFFICER | 20.00 |
Highest
|
$0 | $13,158 | $180,520 |
| VEDA JACKSON | CONTROLLER | 20.00 |
Highest
|
$0 | $19,505 | $167,426 |
| TIM JOHNSTONE | INTERIM CEO | 15.00 |
Officer
|
$0 | $0 | $88,000 |
| GINGER GARDNER MD | CHAIRMAN | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LINDA DUSKA MD | SECRETARY-TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DAVID MUTCH MD | PAST CHAIRMAN | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ERIN MEDLIN MD | COMMUNICATIONS CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHARLES LANDEN MD | RESEARCH CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| SHANNON ARMBRUSTER MD | PATIENT EDUCATION CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMIE BAKKUM-GAMEZ MD | DEVELOPMENT COMMITTEE CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHANIE BLANK MD | NOMINATING COMMITTEE CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANGELES ALVAREZ-SECORD MD | SGO PRESIDENT | 1.00 |
Director
|
$0 | $0 | $0 |
| WENDY BREWSTER MD PHD | HONORS AND AWARDS CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| AMANDA NICKLES FADER MD | HONORS AND AWARDS CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| ELOISE CHAPMAN-DAVIS | DIHE REP | 1.00 |
Director
|
$0 | $0 | $0 |
| MONICA JONES MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| WENDEL NAUMANN MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SUSAN MODESITT MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW POWELL | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| NAVYA NAIR MD | DIHE VICE CHAIR (EX-OFFICIO) - TERM | 1.00 |
Director
|
$0 | $0 | $0 |
| CHAD HAMILTON MD | BOARD MEMBER - TERM | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $2,506,604 | $2,049,930 | $7,344,658 | $456,674 |
| 2022 | $2,355,407 | $1,813,408 | $6,720,975 | $541,999 |
| 2021 | $2,524,783 | $1,684,164 | $6,957,430 | $840,619 |
| 2020 | $1,717,370 | $1,133,923 | $5,428,766 | $583,447 |
| 2019 | $1,655,066 | $1,627,337 | $4,566,757 | $27,729 |
| 2018 | $2,076,760 | $1,940,254 | $4,334,511 | $136,506 |
Compare FOUNDATION FOR WOMEN'S CANCER with other nonprofits in Illinois and across the country.